CareDx Shares Outstanding 2013-2024 | CDNA
CareDx shares outstanding from 2013 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| CareDx Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 54 |
| 2022 | 53 |
| 2021 | 52 |
| 2020 | 46 |
| 2019 | 42 |
| 2018 | 36 |
| 2017 | 23 |
| 2016 | 16 |
| 2015 | 12 |
| 2014 | 9 |
| 2013 | 1 |
| 2012 | 1 |
| CareDx Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-03-31 | 52 |
| 2023-12-31 | 54 |
| 2023-09-30 | 54 |
| 2023-06-30 | 54 |
| 2023-03-31 | 54 |
| 2022-12-31 | 53 |
| 2022-09-30 | 53 |
| 2022-06-30 | 53 |
| 2022-03-31 | 53 |
| 2021-12-31 | 52 |
| 2021-09-30 | 53 |
| 2021-06-30 | 52 |
| 2021-03-31 | 51 |
| 2020-12-31 | 46 |
| 2020-09-30 | 49 |
| 2020-06-30 | 45 |
| 2020-03-31 | 43 |
| 2019-12-31 | 42 |
| 2019-09-30 | 42 |
| 2019-06-30 | 42 |
| 2019-03-31 | 42 |
| 2018-12-31 | 36 |
| 2018-09-30 | 37 |
| 2018-06-30 | 36 |
| 2018-03-31 | 30 |
| 2017-12-31 | 23 |
| 2017-09-30 | 23 |
| 2017-06-30 | 21 |
| 2017-03-31 | 21 |
| 2016-12-31 | 16 |
| 2016-09-30 | 19 |
| 2016-06-30 | 14 |
| 2016-03-31 | 12 |
| 2015-12-31 | 12 |
| 2015-09-30 | 12 |
| 2015-06-30 | 12 |
| 2015-03-31 | 12 |
| 2014-12-31 | 9 |
| 2014-09-30 | 11 |
| 2014-06-30 | 7 |
| 2014-03-31 | 1 |
| 2013-12-31 | 1 |
| 2013-09-30 | 1 |
| 2013-06-30 | 1 |
| 2013-03-31 | 1 |
| 2012-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.794B | $0.280B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.258B | 15.59 |
| Cencora (COR) | United States | $44.266B | 17.26 |
| ICON (ICLR) | Ireland | $26.033B | 24.58 |
| DiDi Global (DIDIY) | China | $23.379B | 0.00 |
| Avantor (AVTR) | United States | $17.056B | 25.11 |
| CochLear (CHEOY) | Australia | $14.191B | 0.00 |
| Viatris (VTRS) | United States | $13.264B | 3.96 |
| Revvity (RVTY) | United States | $13.145B | 23.06 |
| Natera (NTRA) | United States | $12.958B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.348B | 40.62 |
| Charles River Laboratories (CRL) | United States | $11.993B | 22.96 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.923B | 0.00 |
| Solventum (SOLV) | United States | $11.243B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.782B | 0.00 |
| HealthEquity (HQY) | United States | $6.591B | 49.24 |
| Organon (OGN) | United States | $5.491B | 5.21 |
| Bausch + Lomb (BLCO) | Canada | $5.234B | 20.97 |
| Doximity (DOCS) | United States | $4.386B | 32.65 |
| PACS (PACS) | United States | $4.041B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.426B | 31.35 |
| Sotera Health (SHC) | United States | $3.227B | 15.83 |
| Life Times (LTH) | United States | $2.939B | 30.79 |
| GoodRx Holdings (GDRX) | United States | $2.627B | 95.00 |
| Progyny (PGNY) | United States | $2.617B | 45.05 |
| AMN Healthcare Services Inc (AMN) | United States | $2.370B | 9.39 |
| Premier (PINC) | United States | $2.365B | 8.85 |
| Agilon Health (AGL) | United States | $2.262B | 0.00 |
| NovoCure (NVCR) | Jersey | $2.187B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.161B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.936B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.618B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.338B | 0.00 |
| Embecta (EMBC) | United States | $0.842B | 5.73 |
| Pediatrix Medical (MD) | United States | $0.714B | 7.57 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Auna S.A (AUNA) | Luxembourg | $0.639B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.559B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.558B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.547B | 0.00 |
| Enhabit (EHAB) | United States | $0.453B | 45.20 |
| Sonida Senior Living (SNDA) | United States | $0.451B | 0.00 |
| LifeMD (LFMD) | United States | $0.384B | 0.00 |
| ModivCare (MODV) | United States | $0.384B | 7.18 |
| MultiPlan (MPLN) | United States | $0.364B | 0.00 |
| Beauty Health (SKIN) | United States | $0.346B | 0.00 |
| DocGo (DCGO) | United States | $0.344B | 18.33 |
| Ascend Wellness Holdings (AAWH) | United States | $0.281B | 0.00 |
| Sharecare (SHCR) | United States | $0.273B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.271B | 0.00 |
| Biodesix (BDSX) | United States | $0.171B | 0.00 |
| So-Young (SY) | China | $0.126B | 42.33 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| Oncology Institute (TOI) | United States | $0.067B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.051B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 6.77 |
| Nutex Health (NUTX) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |